Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.22.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Revenue from awards $ 0 $ 647,824
Operating expenses:    
Research and development 3,286,236 10,720,823
General and administrative 5,230,923 5,341,197
Total operating expenses 8,517,159 16,062,020
Operating loss (8,517,159) (15,414,196)
Other income (expense), net:    
Other income (expense), net (193,351) (15,094)
Interest income (expense), net (458,909) (646,550)
Change in fair value of derivative liability 0 (6,000)
Foreign currency exchange gain (loss), net (267,823) 16,672
Other income (expense), net (920,083) (650,972)
Net loss $ (9,437,242) $ (16,065,168)
Net loss per share, basic and diluted $ (0.08) $ (0.14)
Weighted average number of common shares outstanding, basic and diluted 125,243,242 116,344,900
Comprehensive loss:    
Net loss $ (9,437,242) $ (16,065,168)
Other comprehensive income (loss):    
Unrealized gain (loss) on marketable debt securities (107,248) (28,765)
Total other comprehensive income (loss) (107,248) (28,765)
Total comprehensive loss $ (9,544,490) $ (16,093,933)